SMH
CEMI

Sanders Morris Harris’s Chembio diagnostics, Inc. CEMI Stock Holding History

Sanders Morris Harris’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-183,584
Closed -$990K – 350
2020
Q4 		$990K Buy
+183,584
New +$948K 0.23% 82

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sanders Morris Harris's CEMI Position: Q1 2021 in Review

Sanders Morris Harris sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2021, closing a stake of 183,584 shares — an estimated $990K sold.

Sanders Morris Harris first reported a position in CEMI in Q4 2020 and held it in 1 quarter. The position peaked at $990K in Q4 2020. 72 funds tracked by Wall St. Rank hold CEMI as of Q1 2021.

  • Sanders Morris Harris reported no remaining Chembio diagnostics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Sanders Morris Harris sold 183,584 Chembio diagnostics, Inc. shares in Q1 2021, an estimated $990K.
  • Sanders Morris Harris first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 1 quarter.
  • Sanders Morris Harris's Chembio diagnostics, Inc. position peaked at $990K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2021.

Based on Sanders Morris Harris's 13F filing for Q1 2021, filed 14 Apr 2021.